MAPK8 and neoplasm: Probiotic-derived ferrichrome acts as a tumor-suppressive molecule via the c-Jun N-terminal kinase (JNK) signaling pathway against cancerous IECs to a greater extent than conventional chemotherapeutic drugs, including cisplatin and 5-FU [223].